Jefferies Raises Price Target as Sagent Pharmaceuticals (SGNT) Agrees to Acquire 5 Injectable ANDAs
Tweet Send to a Friend
Jefferies reiterated a Hold rating on Sagent Pharmaceuticals (NASDAQ: SGNT), and raised the price target to $15.00 (from $13.00), as ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
